Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation
Cells · 23.08.2023 · 12 (17) · 2130
DOI: 10.3390/cells12172130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 23.08.2023. Verfasst von Christopher Beneduce und 9 weiteren Autor:innen. Beteiligte Einrichtung: Momenta Pharmaceuticals Inc., Cambridge, MA 02142, USA. Hauptthemen laut MEDLINE: Antibodies, Environment. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immunoglobulin (IgG) Fc glycosylation has been shown to be important for the biological activity of antibodies. Fc sialylation is important for the anti-inflammatory activity of IgGs. However, evaluating the structure–activity relationship (SAR) of antibody Fc glycosylation has been hindered using simplified in vitro models in which antibodies are often displayed in monomeric forms. Presenting antibodies in monomeric forms may not accurately replicate the natural environment of the antibodies when binding their antigen in vivo. To address these limitations, we used different Fc-containing molecules, displaying their Fc domains in monovalent and multivalent fashion. Given the inhibitory role of Fc gamma receptor IIb (FcγRIIb) in autoimmune and inflammatory diseases, we focused on evaluating the impact of Fc sialylation on the activation of FcγRIIb. We report for the first time that in human cellular systems, sialic acid mediates the induction of FcγRIIb phosphorylation by IgG-Fc when the IgG-Fc is displayed in a multivalent fashion. This effect was observed with different types of therapeutic agents such as sialylated anti-TNFα antibodies, sialylated IVIg and sialylated recombinant multivalent Fc products. These studies represent the first report of the specific effects of Fc sialylation on FcγRIIb signaling on human immune cells and may help in the characterization of the anti-inflammatory activity of Fc-containing therapeutic candidates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Momenta Pharmaceuticals Inc., Cambridge, MA 02142, USA.
- Janssen Research & Development, Cambridge, MA 02142, USA.
Zitieren
APA
Beneduce, C., Nguyen, S., Washburn, N., Schaeck, J., Meccariello, R., Holte, K., Ortiz, D., Manning, A. M., Bosques, C. J., & Kurtagic, E. (2023). Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation. Cells, 12(17), 2130. https://doi.org/10.3390/cells12172130
Vancouver
Beneduce C, Nguyen S, Washburn N, Schaeck J, Meccariello R, Holte K, et al. Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation. Cells. 2023;12(17):2130. doi:10.3390/cells12172130
BibTeX
@article{Beneduce2023,
author = {Beneduce, Christopher and Nguyen, Stephanie and Washburn, Nathaniel and Schaeck, John and Meccariello, Robin and Holte, Kimberly and Ortiz, Daniel and Manning, Anthony M and Bosques, Carlos J and Kurtagic, Elma},
title = {Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on Sialylation},
journal = {Cells},
year = {2023},
volume = {12},
number = {17},
pages = {2130},
doi = {10.3390/cells12172130}
}
EUVIMED